GlassScriptPhysician profile
Diana Macaulay
NPI 1447722707
$3,443.02
in general payments reported to CMS, 2019-2025
19 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $429 · 2022: $849 · 2023: $774 · 2024: $374 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,164.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,239.82 | 2022-2025 | |
| Gilead Sciences, INC. | $346.41 | 2022-2023 | Vemlidy |
| Polynovo North America LLC | $208.69 | 2025 | Novosorb Btm |
| Astrazeneca Pharmaceuticals LP | $193.18 | 2022-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $173.27 | 2021-2022 | |
| Acera Surgical, INC. | $160.72 | 2024 | Restrata Wound Matrix |
| Genentech USA, INC. | $150.00 | 2021 | |
| Calliditas Therapeutics US INC. | $125.00 | 2023 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Rexulti |
| Ultragenyx Pharmaceutical INC. | $125.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $124.68 | 2021 | |
| Sage Therapeutics, LLC | $76.24 | 2023 | |
| Urgo Medical North America, LLC | $75.32 | 2025 | Urgoclean Ag |
| Smith+Nephew, INC. | $63.79 | 2022-2024 | Collagenase Santyl |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $49.25 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Novo Nordisk INC | $40.00 | 2023 | Wegovy |
| Mylan Specialty L.P. | $22.86 | 2023 | Yupelri |
| Exact Sciences Corporation | $18.79 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Macaulay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.